Industries > Pharma > Blood Preparation Market Report 2019-2029

Blood Preparation Market Report 2019-2029

Analysis by Product Type (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic and Anticoagulants Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, And Others), Plus Company and Country Analysis and Forecasts

PAGES: 185
SUBMARKET: Diagnostics

WOOCS 2.2.1
SKU: PHA0428 Categories: , Tag:

Market Definition:
• Blood is a mixture of cellular elements, colloids and crystalloids. Different blood components have different relative density, sediment rate and size. Functional efficiency of each component is dependent on appropriate processing and proper storage.
• Blood is collected in a primary bag that contains anticoagulant-preservatives. Different components need different storage conditions and temperature requirements for therapeutic efficacy.

Market Overview and Trends
• South-east Asian countries such as Indonesia, India, Thailand and Myanmar are at highest risk of disease incidence. Strong product pipeline of anti-thrombotic and anticoagulant drugs coupled with rising awareness about blood donation in developing countries should propel industry growth.
• Blood and blood components market of global blood preparation market is expected to be growing due to increasing application of blood components and rising prevalence of bleeding disorders requiring blood transfusion.
• Organizations, such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), are taking initiatives for raising awareness levels via programs that aim to prevent thrombosis-associated complications in early stages
• As per NIH 2018 data, nearly 100,000 to 300,000 people in the U.S. die due to venous thrombosis annually. Anti-thrombotic and anticoagulants market is anticipated to witness high growth over the forecast timeframe owing to growing adoption of anti-thrombotic drugs to reduce mortality due to thrombosis.

Market Dynamics:

Factors Influencing the Market Growth:
• Growing demand for blood and its components in surgical procedures is expected to be a key factor driving the market.
• Growing geriatric population base and rising healthcare expenditures are likely to boost the market further.
• The introduction of novel technologies along with the increasing usage of plasma in pharmaceutical industry is further projected to contribute to the market growth.
• Various governments across the globe are focusing on increasing the number of blood donations through reimbursement policies, such as monetary incentives for donors. Further results in the growth of the global market

Factors Restraining the Market Growth:
• Risk of infection transmission through transfused blood is the main factor which is hindering the growth of blood preparation market.

Market Segmentation 2019-2029:
The Blood preparation market is segmented on the product type, application, and geography.

Product Type
• Whole Blood Market, 2019-2029
• Blood Components Market, 2019-2029
• Blood Derivatives Market, 2019-2029

Antithrombotic & Anticoagulants
• Platelet Aggregation Inhibitors Market, 2019-2029
• Fibrinolytics Market, 2019-2029
• Anticoagulants Market, 2019-2029

• Thrombocytosis Market, 2019-2029
• Pulmonary Embolism Market, 2019-2029
• Renal Impairment Market, 2019-2029
• Angina Blood Vessel Complications Market, 2019-2029
• Others Market, 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Blood preparation market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
• In June 2017, Portola Pharmaceuticals, Inc. received FDA approval for the commercial launch of Bevyxxa, a novel oral anticoagulant drug

Major Market Players:
straZeneca PLC; Sanofi S.A.; LEO Pharma A/S; Bristol-Myers Squibb Company; Baxter International, Inc.; Pfizer, Inc.; Portola Pharmaceuticals, Inc.; and GlaxoSmithKline PLC

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Download sample pages

Complete the form below to download your free sample pages for Blood Preparation Market Report 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Blood Preparation Market Report 2019-2029

Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021


Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021


Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021


Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021